Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SABS

SAB Biotherapeutics (SABS)

SAB Biotherapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SABS
FechaHoraFuenteTítuloSímboloCompañía
13/08/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
12/08/202416:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SABSSAB Biotherapeutics Inc
08/08/202415:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SABSSAB Biotherapeutics Inc
31/07/202416:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SABSSAB Biotherapeutics Inc
31/07/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSSAB Biotherapeutics Inc
20/05/202416:45GlobeNewswire Inc.SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company UpdatesNASDAQ:SABSSAB Biotherapeutics Inc
06/05/202406:15GlobeNewswire Inc.SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of DirectorsNASDAQ:SABSSAB Biotherapeutics Inc
16/04/202406:15GlobeNewswire Inc.SAB Biotherapeutics Provides SAB-142 Trial UpdateNASDAQ:SABSSAB Biotherapeutics Inc
08/04/202406:15GlobeNewswire Inc.SAB Biotherapeutics to Present at INNODIA Annual MeetingNASDAQ:SABSSAB Biotherapeutics Inc
04/04/202406:15GlobeNewswire Inc.SAB Biotherapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
29/03/202406:15GlobeNewswire Inc.SAB Biotherapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:SABSSAB Biotherapeutics Inc
25/03/202409:15GlobeNewswire Inc.SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza TreatmentNASDAQ:SABSSAB Biotherapeutics Inc
23/02/202407:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
08/02/202407:00GlobeNewswire Inc.SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
02/02/202406:30GlobeNewswire Inc.SAB Biotherapeutics Announces Executive Leadership ChangeNASDAQ:SABSSAB Biotherapeutics Inc
26/01/202415:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SABSSAB Biotherapeutics Inc
23/01/202416:58GlobeNewswire Inc.SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SABSSAB Biotherapeutics Inc
02/01/202415:30GlobeNewswire Inc.SAB Biotherapeutics Announces 1-for-10 Reverse Stock SplitNASDAQ:SABSSAB Biotherapeutics Inc
18/12/202308:34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
08/12/202316:26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SABSSAB Biotherapeutics Inc
29/11/202306:30GlobeNewswire Inc.SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSSAB Biotherapeutics Inc
28/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SABSSAB Biotherapeutics Inc
20/11/202315:45Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:SABSSAB Biotherapeutics Inc
20/11/202306:30GlobeNewswire Inc.SAB Biotherapeutics Appoints Katie Ellias to the Board of DirectorsNASDAQ:SABSSAB Biotherapeutics Inc
15/11/202320:10Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SABSSAB Biotherapeutics Inc
14/11/202306:30GlobeNewswire Inc.SAB Biotherapeutics Announces Completion of $67.1 Million Financing to Advance Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSSAB Biotherapeutics Inc
14/11/202306:15GlobeNewswire Inc.SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company UpdatesNASDAQ:SABSSAB Biotherapeutics Inc
09/11/202306:30GlobeNewswire Inc.SAB Biotherapeutics to Present at Piper Sandler Healthcare ConferenceNASDAQ:SABSSAB Biotherapeutics Inc
03/11/202316:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SABSSAB Biotherapeutics Inc
24/10/202306:30GlobeNewswire Inc.SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial OfficerNASDAQ:SABSSAB Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SABS

Su Consulta Reciente

Delayed Upgrade Clock